Free COVID-19 Therapeutics Now Available!
Happy Monday, RHC community!
We have an exciting announcement to share: all CMS-certified RHCs may now enroll in the HRSA RHC COVID-19 Therapeutics Program to receive a direct supply of free COVID-19 Antivirals!
This program provides RHCs with access to COVID-19 therapeutics, Paxlovid and Lagevrio (Molnupiravir), shipped directly to you. With the increase in COVID-19 due to new variants, we encourage all RHCs to enroll in all HRSA COVID Programs to ensure COVID-19 tests, therapeutics, and vaccines remain available for your patients.
To be eligible for the RHC COVID-19 Therapeutics Program, your clinic must have a formal relationship with an onsite or offsite pharmacy and/or your RHC and state guidelines must allow your medical providers to prescribe and dispense medication at point of care. COVID-19 therapeutics can be shipped directly to your RHC or that pharmacy with which your RHC has a formal relationship.
If your RHC is already enrolled in the HRSA RHC COVID-19 Testing Supply Program and/or the RHC COVID-19 Vaccine Distribution Program, you are already familiar with the Health Partner Ordering Portal (HPOP). By enrolling in the Therapeutics Program, your RHC will gain access to the therapeutics module (TPOP) in HPOP to directly place orders. If your RHC is not yet enrolled in these programs, that is okay too! Please visit the Therapeutics Program page on NARHC.org to review enrollment instructions.
With the addition of this program, your RHC may also become a recognized ASPR Test to Treat site. Your RHC can utilize free testing supplies through the HRSA RHC COVID-19 Testing Supply Program, and treat patients as needed with the therapeutics distributed through the new RHC COVID-19 Therapeutics Program. Once your RHC is enrolled in both programs and has placed your first therapeutics order, email [email protected] to be formally recognized as a Test to Treat site! Visit https://bit.ly/3NU1fwV to find participating sites.
Please visit NARHC.org for program FAQs, or email us with any questions at [email protected]!
We recognize and thank you for your continued persistence throughout the COVID-19 pandemic.
Sincerely,
Mo Sullivan
NARHC Technical Assistance Specialist